Evidence map›Paper›PMID 25680637›Full record

ReviewMolecular neurobiology2016

Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator.

Wei Duan, Yu-Ping Zhang, Zhi Hou, Chen Huang, He Zhu, Chun-Qing Zhang, Qing Yin

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 174 papers.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 305 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Necroptosis in Down Syndrome.Cell death & disease · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Wei DuanDepartment of Neurology, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China.
Yu-Ping ZhangDepartment of Pediatrics, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China.
Zhi HouDepartment of Neurosurgery, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China.
Chen HuangDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37232, USA.
He ZhuDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, 37232, USA.
Chun-Qing ZhangDepartment of Neurosurgery, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China. cqzhang@tmmu.edu.cn.
Qing YinDepartment of Rehabilitation and Physical Therapy, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China. qingyin646891@yahoo.com.
Army Medical University · CNVanderbilt Health · USVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal nuclei (NeuN) is a well-recognized "marker" that is detected exclusively in post-mitotic neurons and was initially identified through an immunological screen to produce neuron-specific antibodies. Immunostaining evidence indicates that NeuN is distributed in the nuclei of mature neurons in nearly all parts of the vertebrate nervous system. NeuN is highly conserved among species and is stably expressed during specific stages of development. Therefore, NeuN has been considered to be a reliable marker of mature neurons for the past two decades. However, this role has been challenged by recent studies indicating that NeuN staining is variable and even absent during certain diseases and specific physiological states. More importantly, despite the widespread use of the anti-NeuN antibody, the natural identity of the NeuN protein remained elusive for 17 years. NeuN was recently eventually identified as an epitope of Rbfox3, which is a novel member of the Rbfox1 family of splicing factors. This identification might provide a novel perspective on NeuN expression during both physiological and pathological conditions. This review summarizes the current progress on the biochemical identity and biological significance of NeuN and recommends caution when applying NeuN immunoreactivity as a definitive marker of mature neurons in certain diseases and specific physiological states.

Indexed as

Alternative SplicingAnimalsAntigens, NuclearAxotomyBiomarkersCell NucleusCells, CulturedCytoplasmEpitopesGene Expression RegulationHumansNerve Tissue ProteinsNervous System DiseasesNeurodevelopmental DisordersNeuronsRNA Splicing FactorsAntigens, NuclearBiomarkersEpitopesNerve Tissue Proteinsneuronal nuclear antigen NeuN, humanRNA Splicing FactorsMature neuronsNeuNNeuronal markerRbfox3Splicing regulator

Identifiers

PMID25680637
OpenAlexW2039372333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.